Skip to main content

Tobacco Companies Dibersify Into 'Pharmaceuticals'

Provider Provider in Home with Senior Patients
Top

Scientific investigators from the University of California, San Francisco (UCSF) wrote in the Annals of Medicine that the tobacco industry is pursuing pharmaceutical development to achieve “long-term nicotine maintenance, rather than total tobacco cessation.” The industry’s approach researchers say is based on a couple of false beliefs: most smokers cannot quit; and for those smokers who do quit, it is only with pharmacotherapy. According to the literature, 90 percent of smokers who quit do so cold turkey. Read more about this public health issue in this Reuters article.

Home